Melanie Weres
Acute Care · Jacksonville, FLNPI 1578671798
Payments from drug & device makers
What this record shows
This record is dominated by other: $30,000 of the $36,680 with a category attached, or 81.8%. Angiodynamics, Inc. accounts for 81.8% of it on its own, with 32 other manufacturers making up the rest. Among acute care clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 330 payments — averaging $111.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$30K
- Novartis$1K
- Boehringer Ingelheim$744
- Abiomed$651
- Abbott$633
- Merck$608
- plus $3K from 27 others
What the payments were for
- Food & beverage$6,68018%
- Other$30,00082%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 2 | $30,000 |
| Novartis | 67 | $1,082 |
| Boehringer Ingelheim | 37 | $744 |
| Abiomed | 9 | $651 |
| Abbott | 27 | $633 |
| Merck | 28 | $608 |
| Johnson & Johnson | 35 | $582 |
| Actelion Pharmaceuticals US, Inc. | 25 | $550 |
| Pfizer | 16 | $250 |
| Bayer | 11 | $206 |
| Impulse Dynamics (USA) Inc. | 7 | $197 |
| Amgen | 11 | $147 |
| Scpharmaceuticals Inc. | 2 | $131 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $126 |
| E.r. Squibb & Sons, L.L.C. | 6 | $104 |
| Esperion Therapeutics, Inc. | 7 | $99 |
| Heartflow, Inc. | 2 | $86 |
| Boston Scientific | 3 | $59 |
| Novo Nordisk | 3 | $54 |
| Medtronic | 3 | $53 |
| AstraZeneca | 4 | $51 |
| Philips North America LLC | 2 | $35 |
| AbbVie | 2 | $31 |
| Biotronik Inc. | 2 | $31 |
| Lexicon Pharmaceuticals, Inc. | 1 | $30 |
| Cardiovascular Systems Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Advanced Respiratory, Inc | 1 | $17 |
| Apria Healthcare LLC | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $13 |
| Chiesi USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$36,680 in reported general payments places this provider in the 95th percentile of 1,150 acute care providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 155 | $122,154 |
| XareltoRivaroxaban | 108 | $106,011 |
| Repatha SureclickEvolocumab | 65 | $97,661 |
| EntrestoSacubitril/Valsartan | 59 | $53,706 |
| JardianceEmpagliflozin | 15 | $6,558 |
| Droxidopa | 14 | $5,380 |
| Midodrine Hcl | 61 | $2,396 |
| Ranolazine ErRanolazine | 24 | $1,847 |
| ClopidogrelClopidogrel Bisulfate | 202 | $1,205 |
| SotalolSotalol Hcl | 71 | $1,092 |
| Metoprolol Succinate | 77 | $1,049 |
| Prasugrel Hcl | 24 | $874 |
| Atorvastatin Calcium | 111 | $857 |
| Rosuvastatin Calcium | 104 | $812 |
| Losartan Potassium | 116 | $712 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $250 | $122,154155 claims |
| Johnson & JohnsonXarelto | $582 | $106,011108 claims |
| NovartisEntresto | $1,082 | $53,70659 claims |
| Boehringer IngelheimJardiance | $744 | $6,55815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,150 acute care providers in Florida.
Other acute care in Jacksonville
- Amanda PeacockJacksonville$81K
- Jayne JaramilloJacksonville$27K
- David BradshawJacksonville$12K
- Melisa WilsonOrlando$214K
- Katrina RileyTampa$66K
- Diane GrayLake Mary$49K
- Heather RamousSafety Harbor$38K
- Melissa HamiltonTampa$23K
- Kimberly GrantAltamonte Springs$20K
- Julie ElliottWinter Haven$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.